Table 1.
Information about the 14 selected lncRNAs-SNPs.
| LncRNA | logFC | p-Value 1 | DE Subtype | SNP | OR | p-Value 2 | C.I | MAF |
|---|---|---|---|---|---|---|---|---|
| AC020916.1 | 1.99 | 1.27 × 10−147 | <ER+ | rs2594714 | 1.04 | 1 × 10−8 | 1.01–1.05 | 0.42 |
| AC093297.2 | 1.86 | 2.70 × 10−15 | <ER+/>HER+ | rs7716600 | 1.24 | 7 × 10−7 | 1.14–1.34 | 0.27 |
| AL358075.2 | 1.45 | 3.39 × 10−11 | <HER2+ | rs1707302 | 1.04 | 3 × 10−8 | 1.02–1.05 | 0.37 |
| AQP4-AS1 | 0.87 | 0.000000000937 | >ER+ | rs527616 | 1.03 | 7 × 10−15 | 1.02–1.05 | 0.23 |
| CASC16 | 1.92 | 0.00000000000000957 | >ER+ | rs4784227/rs3803662 | 1.23 | 4 × 10−117 | 1.2–1.25 | 0.25 |
| CRYZL2P-SEC16B−201 | −0.80 | 1.90 × 10−12 | >HER2+ | rs575908 | 1.03 | 3 × 10−6 | 0.019–0.045 | 0.35 |
| LINC-PINT | −0.69 | 0.00000114 | >HER− | rs68056147 | 1.05 | 5 × 10−13 | 0.037–0.064 | 0.24 |
| LINC02224 | 3.92 | 3.14 × 10−100 | <ER+/>HER+ | rs4415084 | 1.17 | 8 × 10−11 | 1.11–1.22 | 0.46 |
| LINC01977 | 1.48 | 5.16 × 10−19 | <ER+ | rs745570 | 1.03 | 4 × 10−10 | 1.01–1.05 | 0.38 |
| LINC00511 | 1.72 | 2.70 × 10−14 | >ER+ | rs11652463 | 1.04 | 8 × 10−8 | 0.025–0.055 | 0.43 |
| LINC00536 | 1.05 | 0.0000143 | >ER+ | rs13267382 | 1.03 | 2 × 10−11 | 1.03–1.07 | 0.34 |
| LINC00578 | 1.91 | 2.70 × 10−16 | <ER+/<HER+ | rs7430456 | 1.02 | 5 × 10−6 | 0.017–0.042 | 0.44 |
| MEG3 | −1.93 | 2.53 × 10−47 | >ER+ | rs2295389 | 1.03 | 2 × 10−6 | 0.02–0.049 | 0.27 |
| MIR4435-2HG | 0.88 | 6.77 × 10−10 | <HER2+ | rs200484318 | 1.04 | 7 × 10−6 | 0.024–0.062 | 0.36 |
Legend: p-value 1—p value referent to differential expression analysis considering BC tumor × Normal breast/DE Subtype—BC subtype that showed significant different of the lncRNA expression/OR—Odds-Ratio/p-value 2—p value referent to GWAS analysis/C.I.—Confidence interval/MAF = Minor allele frequency. SNPs colored in red are the selected ones.